These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8564397)

  • 1. Identification of an aldose reductase inhibitor site by affinity labeling.
    Kador PF; Lee YS; Rodriguez L; Sato S; Bartoszko-Malik A; Abdel-Ghany YS; Miller DD
    Bioorg Med Chem; 1995 Oct; 3(10):1313-24. PubMed ID: 8564397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The aldose reductase inhibitor site.
    Kador PF; Kinoshita JH; Sharpless NE
    Metabolism; 1986 Apr; 35(4 Suppl 1):109-13. PubMed ID: 3083201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of human aldehyde reductase: characterization of the active site pocket.
    Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
    Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
    Carper DA; Hohman TC; Old SE
    Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of aldehyde reductase by aldose reductase inhibitors.
    Sato S; Kador PF
    Biochem Pharmacol; 1990 Sep; 40(5):1033-42. PubMed ID: 2117925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacophor requirements of the aldose reductase inhibitor site.
    Kador PF; Sharpless NE
    Mol Pharmacol; 1983 Nov; 24(3):521-31. PubMed ID: 6415401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics and molecular docking studies of an anti-diabetic complication inhibitor fucosterol from edible brown algae Eisenia bicyclis and Ecklonia stolonifera.
    Jung HA; Islam MN; Lee CM; Oh SH; Lee S; Jung JH; Choi JS
    Chem Biol Interact; 2013 Oct; 206(1):55-62. PubMed ID: 23994501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel, potent aldose reductase inhibitors: 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl] methyl]-1-phthalazineacetic acid (zopolrestat) and congeners.
    Mylari BL; Larson ER; Beyer TA; Zembrowski WJ; Aldinger CE; Dee MF; Siegel TW; Singleton DH
    J Med Chem; 1991 Jan; 34(1):108-22. PubMed ID: 1899452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic characteristics of ZENECA ZD5522, a potent inhibitor of human and bovine lens aldose reductase.
    Cook PN; Ward WH; Petrash JM; Mirrlees DJ; Sennitt CM; Carey F; Preston J; Brittain DR; Tuffin DP; Howe R
    Biochem Pharmacol; 1995 Apr; 49(8):1043-9. PubMed ID: 7748183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Probing the inhibitor-binding site of aldose reductase with site-directed mutagenesis.
    Hohman TC; El-Kabbani O; Malamas MS; Lai K; Putilina T; McGowan MH; Wane YQ; Carper DA
    Eur J Biochem; 1998 Sep; 256(2):310-6. PubMed ID: 9760169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The alrestatin double-decker: binding of two inhibitor molecules to human aldose reductase reveals a new specificity determinant.
    Harrison DH; Bohren KM; Petsko GA; Ringe D; Gabbay KH
    Biochemistry; 1997 Dec; 36(51):16134-40. PubMed ID: 9405046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of new inhibitors of aldose reductase from molecular docking and database screening.
    Rastelli G; Ferrari AM; Costantino L; Gamberini MC
    Bioorg Med Chem; 2002 May; 10(5):1437-50. PubMed ID: 11886806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetic and spectroscopic evidence for active site inhibition of human aldose reductase.
    Nakano T; Petrash JM
    Biochemistry; 1996 Aug; 35(34):11196-202. PubMed ID: 8780524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective irreversible inhibitors of aldose reductase.
    Smar MW; Ares JJ; Nakayama T; Itabe H; Kador PF; Miller DD
    J Med Chem; 1992 Mar; 35(6):1117-20. PubMed ID: 1552504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility of aldehyde and aldose reductases of human tissues to aldose reductase inhibitors.
    Srivastava SK; Petrash JM; Sadana IJ; Ansari NH; Partridge CA
    Curr Eye Res; 1982-1983; 2(6):407-10. PubMed ID: 6820339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of aldose reductase inhibition: binding of NADP+/NADPH and alrestatin-like inhibitors.
    Ehrig T; Bohren KM; Prendergast FG; Gabbay KH
    Biochemistry; 1994 Jun; 33(23):7157-65. PubMed ID: 8003482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 'specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil.
    Urzhumtsev A; Tête-Favier F; Mitschler A; Barbanton J; Barth P; Urzhumtseva L; Biellmann JF; Podjarny A; Moras D
    Structure; 1997 May; 5(5):601-12. PubMed ID: 9195881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 2-(arylamino)-4(3H)-quinazolinones as novel inhibitors of rat lens aldose reductase.
    DeRuiter J; Brubaker AN; Millen J; Riley TN
    J Med Chem; 1986 May; 29(5):627-9. PubMed ID: 3084783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of aldose reductase by (2,6-dimethylphenylsulphonyl)nitromethane: possible implications for the nature of an inhibitor binding site and a cause of biphasic kinetics.
    Ward WH; Cook PN; Mirrlees DJ; Brittain DR; Preston J; Carey F; Tuffin DP; Howe R
    Adv Exp Med Biol; 1993; 328():301-11. PubMed ID: 8493907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel spirosuccinimide aldose reductase inhibitors derived from isoquinoline-1,3-diones: 2-[(4-bromo-2-fluorophenyl)methyl]-6- fluorospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrone and congeners. 1.
    Malamas MS; Hohman TC; Millen J
    J Med Chem; 1994 Jun; 37(13):2043-58. PubMed ID: 8027986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.